Skip to main content

Find Clinical Trials

Home
Conditions
Philadelphia Chromosome-Positive

Clinical trial condition

Philadelphia Chromosome-Positive

Explore clinical trials studying Philadelphia Chromosome-Positive. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Philadelphia Chromosome-Positive trial results

Recruiting

Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

NCT06308588

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Montefiore Einstein Comprehensive Cancer Center The Bronx, New York, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

NCT04329325

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Mount Sinai Hospital New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details